showed that miR‐138 could inhibit NSCLC cell growth and tumour growth in nude mice by suppressing the expression of its target genes the enhancer of zeste homolog 2 (EZH2) and 3‐phosphoinositide‐dependent protein kinase‐1 (PDK1) 16, 19. Here, EZH2 is linked to neoplasm.